Similar articles

• Efficacy and safety of a therapeutic interchange from high-dose calcium channel blockers to a fixed-dose combination of amlodipine/benazepril in patients with moderate-to-severe hypertension.

  Hilleman DE, Reyes AP, Wurdeman RL, Faulkner M. Hilleman DE, et al. J Hum Hypertens. 2001 Aug;15(8):559-65. doi: 10.1038/sj.jhh.1001230. J Hum Hypertens. 2001. PMID: 11494095
• Amlodipine/benazepril combination therapy for hypertensive patients nonresponsive to benazepril monotherapy.

  Chrysant SG, Bakris GL. Chrysant SG, et al. Am J Hypertens. 2004 Jul;17(7):590-6. doi: 10.1016/j.amjhyper.2004.03.679. Am J Hypertens. 2004. PMID: 15233978 Clinical Trial.
• Initial angiotensin-converting enzyme inhibitor/calcium channel blocker combination therapy achieves superior blood pressure control compared with calcium channel blocker monotherapy in patients with stage 2 hypertension.

  Jamerson KA, Nwose O, Jean-Louis L, Schofield L, Purkayastha D, Baron M. Jamerson KA, et al. Am J Hypertens. 2004 Jun;17(6):495-501. doi: 10.1016/j.amjhyper.2004.02.003. Am J Hypertens. 2004. PMID: 15177521 Clinical Trial.
• Single-pill combination of amlodipine and valsartan in the management of hypertension.

  Flack JM, Hilkert R. Flack JM, et al. Expert Opin Pharmacother. 2009 Aug;10(12):1979-94. doi: 10.1517/14656560903120899. Expert Opin Pharmacother. 2009. PMID: 19606937 Review.
• Role of combination therapy in the treatment of hypertension: focus on valsartan plus amlodipine.

  Ferri C, Croce G, Desideri G. Ferri C, et al. Adv Ther. 2008 Apr;25(4):300-20. doi: 10.1007/s12325-008-0042-x. Adv Ther. 2008. PMID: 18449492 Review.